Skip to main content

Bristol-Myers Squibb Company



) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 1.3%. By the end of trading, Bristol-Myers Squibb Company rose 47 cents (1.4%) to $32.99 on average volume. Throughout the day, 7.3 million shares of Bristol-Myers Squibb Company exchanged hands as compared to its average daily volume of 9.6 million shares. The stock ranged in a price between $32.51-$33.02 after having opened the day at $32.51 as compared to the previous trading day's close of $32.52. Other companies within the Health Care sector that increased today were:




), up 47.9%,

Rosetta Genomics



), up 44.9%,




), up 29.8%, and

Scroll to Continue

TheStreet Recommends

ARCA biopharma



), up 27%.

Bristol-Myers Squibb Company, a biopharmaceutical company, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products that help patients prevail over serious diseases worldwide. Bristol-Myers Squibb Company has a market cap of $55.45 billion and is part of the


industry. The company has a P/E ratio of 14.7, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are down 6.8% year to date as of the close of trading on Wednesday. Currently there are 12 analysts that rate Bristol-Myers Squibb Company a buy, one analyst rates it a sell, and nine rate it a hold.

TheStreet Ratings rates Bristol-Myers Squibb Company as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, reasonable valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front,




), down 42.9%,

Catalyst Pharmaceutical Partners



), down 34.5%,




), down 13.7%, and

Senesco Technologies



), down 9.3%, were all losers within the health care sector with

Warner Chilcott



) being today's health care sector loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR



) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care